During the winter storm, numerous Louisiana residents lost power and, now, as the storm subsides, thousands are still without power. The National Weather Service (NWS) warned residents of widespread ...
Ricursive Intelligence, a startup building an AI system to design and automatically improve AI chips, has raised $300 million at a $4 billion valuation. The company said Monday the round was led by ...
FPS Overwatch 2 drops the 2 and goes back to being Overwatch as Blizzard launches its biggest update ever next week: 'We want to gain players' confidence, we want them to have trust in the game' MMO ...
After making the obviously poor decision to kill its XPS laptops and desktops in January 2025, Dell started selling 16- and 14-inch XPS laptops again today. “It was obvious we needed to change,” Jeff ...
The holiday season always reminds me that there is such a thing as too much of a good thing. My kids start winter break thrilled—new toys to play with, days at home, permission to veg out. But by the ...
Recursion Pharmaceuticals' AI-based approach has the potential to transform the pharmaceutical industry. However, it is still chasing clinical wins that would demonstrate the power of its strategy.
When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...
On CNBC's “Mad Money Lightning Round,” on Thursday, Jim Cramer said Recursion Pharmaceuticals (NASDAQ: RXRX) has been “horrendous” and he does not like to recommend horrendous stocks. On the earnings ...
'Mad Money' host Jim Cramer weighs in on stocks including: Recursion Pharmaceuticals and NuScale Power. Trump administration's changes to the CFPB cost Americans $19B, a new report says Bad Bunny ...
Monday - Friday, 6:00 - 7:00 PM ET It's that time again! "Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.
In my book, Spoiled, I engage with a group of contemporary Asian American artists who expose and unravel the expectation that their work should heal and repair the wounds of racial difference as ...